Skip to main content

Pfizer Inc(PFE-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low26.23
Day High27.13
Open:26.54
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Pfizer Inc

Select a category then submit the form to load news
Tipranks
Pfizer Adds New Early-Stage Heart Failure Candidate to Its China Pipeline
Motley Fool
Where Will Eli Lilly Stock Be in 10 Years?
Motley Fool
Here's Why I Wouldn't Touch Amarin With a 10‑Foot Pole Given Its Patent and Competition Risks
Stock Target Advisor
Investors Flee Risk on Macro Data and Energy Fears: Market Analysis for March 6th, 2026
Market Analysis for March 6th, 2026
Motley Fool
Here's Why I Wouldn't Touch Regencell Bioscience With a 10‑Foot Pole Right Now
Motley Fool
Tariffs News & Market Chaos
Tipranks
Entera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX)
Zacks Investment Research
Can Pfizer Reignite Growth Amid COVID Declines and Patent Expirations?
Can Pfizer Reignite Growth Amid COVID Declines and Patent Expirations?
Tipranks
Wells Fargo Sticks to Its Hold Rating for Pfizer (PFE)
Motley Fool
Forget Teva: This Dividend Top Dog Is the Real Value Buy Today
Tipranks
Pfizer Advances PF-07328948 Kidney Function Study, Supporting Long-Term Pipeline Value
Investor Brand Network
ParaZero Technologies (NASDAQ: PRZO) Appoints Bat-Sheva Noy as Vice President of Global Sales
Motley Fool
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?
Motley Fool
Higher Income or Ironclad Safety? VCIT vs. IEI
Zacks Investment Research
Immunology, Neuroscience Step Up as Key Growth Engines for J&J
Immunology, Neuroscience Step Up as Key Growth Engines for J&J
Tipranks
Positive Report for Pfizer (PFE) from Argus Research
Zacks Investment Research
BMY Gains 11.4% in a Month: Should You Buy, Sell or Hold the Stock?
BMY Gains 11.4% in a Month: Should You Buy, Sell or Hold the Stock?
Motley Fool
1 Reason I'd Happily Buy Pfizer (PFE) Stock and Never Sell
Zacks Investment Research
Pfizer Stock: Buy, Sell or Hold After Its 11% Rally So Far in 2026?
Pfizer Stock: Buy, Sell or Hold After Its 11% Rally So Far in 2026?
Motley Fool
Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need
Motley Fool
Should You Forget Eli Lilly and Buy This Magnificent High-Yield Dividend Stock Instead?
Tipranks
Pfizer Advances mRNA Flu Vaccine Pipeline With New Phase 2 Trial
Tipranks
Pfizer Quietly Advances New Obesity Shot With Fresh Phase 1 Study Update
Motley Fool
Amneal (AMRX) Q4 2025 Earnings Call Transcript
Motley Fool
OPKO Health (OPK) Q4 2025 Earnings Call Transcript
Tipranks
Pfizer’s Pneumococcal Vaccine Study in China: What the Latest Trial Update Means for PFE Investors
Tipranks
Pfizer Terminates Early-Stage Ulcerative Colitis Drug Study: What Investors Should Watch
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Ionis Pharmaceuticals (IONS), Celldex (CLDX)
Motley Fool
Eli Lilly Just Took 2 Major Steps Forward in the Billion-Dollar Obesity Drug Market. Here's What You Need to Know.
Zacks Investment Research
Can J&J Sustain Its Double-Digit Oncology Growth Streak?
Can J&J Sustain Its Double-Digit Oncology Growth Streak?
Motley Fool
This Dividend Giant Pfizer Could Turn a Boring Healthcare Allocation Into Serious Income
Newswire.ca
Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity

Profile

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.'The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.